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Abstract
GABAA receptor (GABAAR) expression level is inversely correlated with the proliferation rate of astrocytes after stroke or
during malignancy of astrocytoma, leading to the hypothesis that GABAAR expression/activation may work as a cell
proliferation repressor. A number of vasoactive peptides exhibit the potential to modulate astrocyte proliferation, and the
question whether these mechanisms may imply alteration in GABAAR-mediated functions and/or plasma membrane
densities is open. The peptide urotensin II (UII) activates a G protein-coupled receptor named UT, and mediates potent
vasoconstriction or vasodilation in mammalian vasculature. We have previously demonstrated that UII activates a PLC/PIPs/
Ca
2+ transduction pathway, via both Gq and Gi/o proteins and stimulates astrocyte proliferation in culture. It was also shown
that UT/Gq/IP3 coupling is regulated by the GABAAR in rat cultured astrocytes. Here we report that UT and GABAAR are co-
expressed in cerebellar glial cells from rat brain slices, in human native astrocytes and in glioma cell line, and that UII
inhibited the GABAergic activity in rat cultured astrocytes. In CHO cell line co-expressing human UT and combinations of
GABAAR subunits, UII markedly depressed the GABA current (b3c2.a2b3c2.a2b1c2). This effect, characterized by a fast
short-term inhibition followed by drastic and irreversible run-down, is not relayed by G proteins. The run-down partially
involves Ca
2+ and phosphorylation processes, requires dynamin, and results from GABAAR internalization. Thus, activation of
the vasoactive G protein-coupled receptor UT triggers functional inhibition and endocytosis of GABAAR in CHO and human
astrocytes, via its receptor C-terminus. This UII-induced disappearance of the repressor activity of GABAAR, may play a key
role in the initiation of astrocyte proliferation.
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Introduction
Integrated brain function and dysfunction arise from the
complex interactions between a network of multiple cell types
including neurons, c and the microvascular endothelial cells
comprising the cerebral vasculature [1,2,3]. This micro-environ-
ment is a dynamic structure referred as neurovascular unit where
polarized astrocytes have a pivotal role [4], rapidly transducing
synaptic information [2,3,4,5]. In pathological conditions includ-
ing stroke, the astroglial reactivity is characterized by proliferation,
hypertrophy, process extension, increased synthesis of intermedi-
ate filaments, as well as expression of bioactive molecules and their
receptors [6,7,8].
GABAA receptors (GABAAR) are believed to be pentameric
heterooligomers mainly constructed from homologous subunit
types a1–6, b1–3, c1–3, d and e [9,10,11]. The GABAARi s
expressed in neurons but also in glial cells in culture [12], brain
slices [13], acutely isolated hippocampal slices [13], membrane
fractions of the mature rodent brain [14] and also in vivo in healthy
brain [15]. In pathological conditions, a significant decrease of
benzodiazepine sites associated to the GABAAR has been
demonstrated in patients with ischemic cerebrovascular
[15,16,17], Parkinson [18] and Alzheimer [19,20] diseases. It
was also observed a reduced chloride conductance [21], a decrease
in receptor mediated inhibitory post-synaptic potentials [22] and a
marked down-regulation of the GABAAR expression at the cell
surface along with a fast time course [15,23,24]. In reactive and
malignant astrocytes, mRNA levels of GABAAR have been shown
to remain constant before diminution of functional GABAAR
[15,25]. Thus, the disappearance of GABAAR expression is
correlated with higher glial proliferation rate after stroke or during
malignancy of astrocytoma [15,25,26], leading to the hypothesis
that GABAAR expression/activation works as a repressor of cell
proliferation. Investigations on alterations in GABAAR-mediated
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e36319functions, receptor densities or modulation in astrocytes remain
unchallenged. It has been demonstrated that simultaneous
activation of different postsynaptic receptors induces cross-
modulation of their activation properties and receptor membrane
insertion/deletion. Thus, as many neurotransmitters and vasoac-
tive peptides are released by endothelium and astrocytes, and their
receptors are expressed by astrocytes, there is a potential for
complex signaling within the neurovascular unit, involving
receptor cross-talks.
Urotensin II (UII) and its paralog urotensin II-related peptide
URP, are highly efficient vasoactive peptides, which share a fully
conserved C-terminal cyclic CFWKYC core corresponding to the
molecular pharmacophore [26,27,28]. The biological actions of
UII and URP are mediated through activation of a G protein-
coupled receptor named UT. It is now clearly established that
activation of native UII receptors or UT-transfected cell lines is
associated with an increase in polyphosphoinositide (PIPs) turn-
over promoting a cytosolic calcium concentration ([Ca
2+]c) rise
[29,30,31]. UII and UT are expressed in the mammalian
cardiovascular system namely in the myocardium, vascular
smooth muscle cells and endothelial cells [32,33,34,35], affecting
cell proliferation [35,36] or neoangiogenesis [37], stimulating
collagen synthesis and cardiac hypertrophy [34].
In the brain, UII mRNA is particularly abundant in
motoneurons of the medulla oblongata and spinal cord [38,39]
while UT mRNA is widely expressed in various regions of the
central nervous system including the olfactory system, hippocam-
pus, amygdala, hypothalamus, or cerebellum [27]. However,
immunohistochemical studies revealed that UT is expressed in
astroglial processes in vivo [40] and in cultured rat cortical
astrocytes [41]. In this cell type, we have previously demonstrated
that UII activates a PLC/PIPs/Ca
2+ transduction pathway, via
both Gq and Gi/o proteins and stimulates cell proliferation [41,42].
Moreover, a functional interaction between GABAAR and UT
suggested a cross-talk between these two receptors, involved in
astrocyte activity [43]. In this study we demonstrate that activation
of UT receptor induces a long-term inhibition of GABAAR-
mediating chloride currents, a process potentially relevant for
astrocyte proliferation.
Results
GABAAR and UT functional coupling in rat cerebellar
astrocytes
We and others have previously demonstrated that astrocytes
express in vitro and in vivo UT mRNA and/or protein [38,40,41].
As shown in Figure 1Aa and 1b, UT is extensively expressed in
astroglial processes, but also in the sparse mature granule cells
present in co-cultures. In order to investigate a potential cross-talk
between GABAAR and UT in both astrocytes and neurons, patch-
clamp recording of the GABAAR agonist isoguvacine (Iso,
10
24 M) responses was carried out on membrane potentials and
currents of astrocytes in mono-culture, and astrocytes or neurons
in co-culture (Figure 1B and 1C). We established that flat and
proliferating astrocytes in mono-culture (n=31) (Figure 1B) were
rarely responding (only 12% of cells are responding to Iso). In
contrast, astrocytes cultured with cerebellar granule neurons
present a slowly proliferating stellate astrocytic morphology
(n=78) (Figure 1B) and are more responding to the GABAAR
agonist (48% of tested cells). In co-cultured astrocytes, local
perfusion of rat UII (rUII, 10
27 M, 40 s) provoked a marked
inhibition of the amplitude of the depolarization and chloride
current (voltage clamp; 260 mV) evoked by the GABAAR agonist
isoguvacine by 24.267.5% and 3368% (n=5), respectively
(Figure 1C). In contrast, rUII did not affect the Iso-evoked
depolarization and current in cerebellar granule neurons
(Figure 1C). In astrocytes, rUII induced a dose-dependent
inhibition of the current with an EC50 value of 43.6623.7% pM
(Figure 1D). It can be noticed that in some cells, UII tested at
10
28 M, activated a small inward current. These data indicate
that in astrocytes, unlike in neurons, rUII efficiently and markedly
down regulated the GABAergic activity when UT and GABAAR
are co-expressed.
In postnatal day 7 (P7) cerebellar slices, we investigated the
topographic cellular and subcellular distribution of UT in the
different layers. UT protein immunoreactivity was specifically
distributed in particular zones of the cerebellar cortex, in the
Purkinje cell layer (PCL), on fibers irradiating from the thin
molecular cell layer (ML) toward the external granule cell layer
(EGL), and on isolated cells residing in the internal granule cell
layer (IGL) (Figure 2). In particular, UT receptor staining was
present on NeuN-positive mature granule cell bodies (Figure 2A
and 2A9) and also in Purkinje neuronal cell bodies and
ramifications, as revealed by the strong immunofluorescence of
UT in calbindin-positive Purkinje cell soma and dendrites
(Figure 2B and 2B9). Doublecortin (DCX) is a distinctive marker
of granule cells during the period of radial descent along the
Bergmann glia into the cerebellar layers [44]. The DCX
immunoreactivity appeared as a diffuse labeling in the IGL and
densely in the ML, contiguously associated to UT-positive
components but not co-localized (Figure 2C and 2C9). Moreover,
UT was strongly co-localized with GFAP expressed by astrocytes
of the white matter (not shown), and on glial cells (Figure 2D)
including Bergmann cells [45]. At higher magnification, the
double immunofluorescence analysis revealed that Bergmann cell
bodies and fibers were surrounded by yellow co-localizing signals
of UT varicosities and of GFAP-positive filaments (Figure 2D9). In
addition, immunohistochemical analysis showed labeling of the c1
subunit in Purkinje cells, and faint staining in fibers of the ML and
in granule cell bodies of the IGL, co-localizing with UT (Figure 2E
and 2E9). The c2 subunit immunoreactivity was also mainly
detected in Purkinje cells and fibers of the EGL (Figure 2F and
2F9). Thus, it appears that UT and GABAAR subunits are
colocalized in cerebellar Purkinje and glial cell fibers in situ.
UT mediates inhibition of c-composed GABAAR
complexes
The molecular basis for the observed directional decrease in
GABAAR function has been investigated in CHO co-expressing
human UT and ab and/or c GABAAR subunits. GABAAR can be
made from several different subunit families (a1–a6, b1–b3, c1–c3,
r1–3, d, e, p, and h), which come together in various combinations
to form the pentameric receptor [46]. Most receptors are thought
to contain a, b and the third subunit type varying, being often the
c2. Expression of unitary subunits has produced conflicting results,
but some subunits expressed alone [47,48] or as binary
combinations, for instance a1c2 or b2c2, appear to be able to
produce GABA-gated ions channels [49,50,51]. In order to
establish a direct functional link between GABAAR and UT, the
effect of graded concentrations of hUII was studied on the current
evoked by Iso on CHO-UT, expressing different subunit
combinations of GABAAR (Figure 3A). It is observed that hUII
induced inhibition of GABAAR complexes which systematically
contained c1 or c2 subunit (Figure 3A and 3B), and the normalized
data fit yielded various EC50 values and efficacies summarized in
supplementary information (Table S1). In particular, hUII was less
effective on the a2b3c1 and a2b1c1 and totally ineffective on the
a2b3 and a2b1 complexes (Figure 3A and 3B, Table S1).
UII Receptor-Induced Down-Regulation of GABAAR
PLoS ONE | www.plosone.org 2 May 2012 | Volume 7 | Issue 5 | e36319Figure 1. UII-induced depression of GABAAR in UT-expressing cerebellar astrocytes. (Aa, Ab) Double immunofluorescence labeling of UT
(green) and the specific astrocyte marker GFAP (red, Aa), or the mature neuron marker NeuN (red, Ab) in astrocyte-neuron co-culture from P7 rat
cerebellum. Astrocytes, recognized by strong GFAP staining show UT immunoreactivity (arrows), whereas few weaker UT-stained cells express NeuN
(arrowheads), and were likely attributed to mature granule cells (arrowheads, Ab). Nuclei (blue) were counterstained with DAPI. Scale bars, 50 mm. (B)
Phase contrast photomicrograph of astrocytes in mono-culture, or astrocytes and neurons in co-culture at 3 days in vitro. (C) Membrane
depolarizations and currents evoked by the GABAAR agonist isoguvacine (Iso, 10
24 M, 2 s for membrane potential and 5 s for chloride current) in
astrocytes and cerebellar granule neurons before, during rUII (10
27 M, 40 s) application and after 2-min washout. Right, normalized amplitudes
deduced by the mean Iso-evoked depolarization or current obtained before rUII application. (D) Concentration-response relationship of Iso-evoked
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PLoS ONE | www.plosone.org 3 May 2012 | Volume 7 | Issue 5 | e36319As a control, the effect of the GABAAR allosteric inverse
modulator DMCM, hUII and other urotensinergic modulators,
were tested on the a2b3c2 GABAAR function in the absence of
UT. Our data demonstrated that, as expected, DMCM induced
inhibition of the current in most tested cells, and hUII and its
paralog URP failed to affect the amplitude of the current
currents from astrocytes yielding an EC50 value of 43.6623.7 10
212 M. Data are mean 6 SEM of 4 to 6 cells. *, P,0.05; ** P,0.01 compared with the
corresponding control Iso-evoked current.
doi:10.1371/journal.pone.0036319.g001
Figure 2. Co-localization of UT with c subunits in neuron and glial components in rat cerebellum. (A, A9) Double-fluorescence staining
for UT (green) and NeuN (red) showing the presence of UT in both mature (arrowhead, merge, A9) and unidentified cells (arrows, merge, A9) in the
IGL. (B) Co-staining of UT and the marker of Purkinje cells, calbindin (red), in Purkinje cell soma and dendrites (arrowhead, B9). (C) Staining for UT and
the marker of migrating neuroblasts doublecortin DCX (red) depicting a diffuse labeling in the ML. (C9) UT immunopositive fibers contiguous to DCX-
expressing migrating granule cells (merge, yellow, arrowhead). (D, D9) Staining for UT and GFAP (red) in glial fibers (merge, yellow, arrowhead) of the
ML. (E, F) Distribution of UT and the c1 (E) and c2 (F) GABAAR subunits (red), in Purkinje cells (merge, arrowhead) and few extents of glia (merge,
arrow) in the ML and IGL. Nuclei (blue) were counterstained with DAPI. Scale bars, 50 mm (A–F); 20 mm( A 9–F9). EGL, external granule cell layer; IGL,
internal granule cell layer; ML, molecular layer; PCL, Purkinje cell layer. (A9–F9) images of digitally zoomed regions corresponding to the white boxes in
A–F.
doi:10.1371/journal.pone.0036319.g002
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PLoS ONE | www.plosone.org 4 May 2012 | Volume 7 | Issue 5 | e36319Figure 3. Effect of hUII on different GABAAR subunit combinations. (A) Typical Iso-evoked currents at the holding potential of 260 mV, in
the whole-cell configuration, on CHO stably expressing human UT (CHO-UT) and transiently transfected with cDNAs encoding a2b3c2, a2b1c2, a2b3c1,
a2b1c1, b3c2, b1c2, a2b3 or a2b1 subunits of the GABAAR. Iso (10
24 M) was repeatedly applied for 2 s at 2 min intervals and increasing concentrations
of hUII (10
213 to 10
27 M) were bath perfused in the vicinity of cells. (B) Corresponding concentration-response curves for hUII on a2b1c2 and a2b3c2,
a2b1c1 and a2b3c1, b1c2 and b3c2, a2b1 and a2b3 receptor subunits. Data are normalized to the control Iso response immediately prior to lower hUII
concentration application. Data are mean 6 SEM of 3 to 23 cells.
doi:10.1371/journal.pone.0036319.g003
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PLoS ONE | www.plosone.org 5 May 2012 | Volume 7 | Issue 5 | e36319Figure 4. Pharmacological characterization of the UT-mediated inhibition of the GABAAR currents. (A) Whole-cell current
response to Iso (10
24 M, 2 s) recorded in the absence or presence of the benzodiazepine site inverse agonist DMCM (10
25 M), hUII and URP
(10
28 M, each), or UT antagonists [Orn
5]-URP and palosuran (10
26 M, each) in CHO expressing a2, b3 and c2 subunits. Below, summary of the
various experimental conditions (n=3–18). (B) Comparison of the inhibitory effect of hUII and DMCM on CHO-UT-GABAAR, as summarized in
bar graphs (n=25). Bottom row, plot of the positive correlation (r
2=0.8)ofhUII-induced inhibition as function of the DMCM-evoked current
decrease (n=28). (C) Comparison of the inhibitory effect of hUII and URP on CHO-UT-GABAAR as summarized in bar graphs (n=12–54). (D, E)
Effect of [Orn
5]-URP and palosuran in the absence or presence of hUII versus the effect of hUII alone. Right, summary of the various
UII Receptor-Induced Down-Regulation of GABAAR
PLoS ONE | www.plosone.org 6 May 2012 | Volume 7 | Issue 5 | e36319(Figure 4A). The rapid development in recent years of several UT
antagonists has led to the synthesis of [Orn
5]-URP which has been
previously characterized in our laboratory [52,53] and palosuran,
with one such high affinity toward human UT [54,55]. Thus, the
specific rat UT antagonist [Orn
5]-URP (10
26 M), and the primate
UT specific antagonist palosuran (10
26 M), did not modulate the
Iso-evoked current.
To assess the role of c subunit into ab binary complexes in the
UII-induced GABAAR regulation, we tested the effect of DMCM,
as this allosteric modulator exhibits negative effect on GABA
current in cells expressing c2 subunit [56,57] or null effect when c
is not present [56]. We analyzed the effect of hUII (10
28 M)
concomitantly to that of DMCM (10
26 M) on CHO-UT co-
expressing a2b3c2 GABAAR. The amplitude of the hUII-induced
inhibition was plotted as a function of the DMCM-induced
inhibition of chloride currents recorded from twenty five CHO-
UT-GABAAR expressing cells. A linear regression analysis
confirmed the significance of a correlation as represented on the
scatter plot (r
2=0.8, P,0.001) (Figure 4B), suggesting that c2
regulates the degree of UT-mediating inhibition of the GABAergic
activity.
The effects of the different urotensinergic ligands were then
tested on CHO-UT-GABAAR composed of the c2 subunit. We
found that hUII and URP (10
28 M, each) induced a marked
current inhibition by 29.2461.90% (n=54) and 22.963.5%
(n=12), respectively, that persisted during washout for hUII, but
slightly recovered during washout for URP (Figure 4C). In order
to examine whether UT antagonists might counteract the UII-
induced decrease of the GABAergic activity, [Orn
5]-URP and
palosuran were tested. [Orn
5]-URP (10
26 M) significantly, but
weakly inhibited the Iso-evoked current, blocked the effect of the
acute application of hUII, but failed to counteract the prolonged
effect of the peptide on the same cell (Figure 4D). Surprisingly,
palosuran mimicked the hUII-induced inhibition of the Iso-evoked
current, but abolished the irreversible action of hUII during
washout (Figure 4E). This indicates that [Orn
5]-URP or palosuran
may keep their antagonist profile toward UT, but exhibit
‘‘agonistic activity’’ in regard to the GABAAR function.
To test whether activation of the UT/[Ca
2+]c signaling pathway
may be closely linked to the modulation of GABAAR, changes in
[Ca
2+]c evoked by hUII, URP, [Orn
5]-URP and palosuran were
measured by continuous Ca
2+ fluorescence imaging in CHO-UT.
When applied to the bath solution, hUII and URP evoked a
significant and rapid increase of the amplitude of the baseline
[Ca
2+]c by 322% and 341%, respectively (Figure 5A and 5B). The
effect of hUII was irreversible, only partially recovering after 32-
min washout (Figure 5A), as compared with URP whose effect
totally recovered after 16-min washout (Figure 5B). It is also
observed that [Orn
5]-URP (10
26 M) behaved as a partial agonist
(265% of [Ca
2+]c increase) but prevented the sustained effect of
hUII on [Ca
2+]c (Figure 5C). In contrast, palosuran (10
26 M)
failed to evoke a [Ca
2+]c rise and completely blocked the hUII-
induced [Ca
2+]c increase (Figure 5D).
Effect of UT on GABAAR pharmacology and gating
properties
According to the action of UT on GABAAR, we asked the
question whether the pharmacology and gating properties of
GABAAR were affected by UT. Thus, we found that the specific
positive allosteric GABAAR modulator pentobarbital (10
25 M)
directly activated a chloride current, and reversibly potentiated the
Iso-evoked current by 196.28612.33% (Figure S1A). In addition,
SR95531 (10
25 M) and picrotoxin (10
24 M) induced attended
current inhibition by 76.92610.35%, and by 56.7664.33%,
respectively (Figure S1A). This indicates that pharmacological
characteristics of the GABAAR are not altered by the presence of
UT. Next, to determine whether activation of UT might modify
the conductance and selectivity of the GABAAR-channel complex,
the current-voltage (I-V) relationship was studied on CHO-UT co-
expressing a2b3c2 GABAAR subunits. The voltage-dependence of
the cell response to Iso (10
24 M) was investigated in the absence or
presence of hUII and the amplitude of the current was measured at
different holding potentials (Figure S1B). Local perfusion of hUII
(10
28 M) decreased the slope of the I–V curve but did not
significantly shift the chloride reversal potentials (EqCl
2, control,
4.84 mV; hUII, 3.36 mV), closed to the theoretical EqCl
2 value
calculated from the Nernst equation, based on the external and
internal chloride concentrations used during recording (see
Materials and Methods section). It is observed that hUII-induced
inhibition of the Iso-evoked current recorded at 260 mV
(26.9366.35%) and +60 mV (37.06611.25%) was very similar
and did not significantly depend on the holding potential (Figure
S1B).
The subunit composition determines the GABA sensitivity and
the pharmacological properties of the GABAAR [9] as well as the
time course of the GABA response referred as desensitization and
deactivation of chloride current [58,59,60]. To clearly assess the
mechanism of UT-mediating inhibitions of the GABA current,
hUII was applied on CHO-UT-GABAAR on the fast component
of current desensitization. As shown in Figure 6, the current
evoked by Iso showed a slow decay during continuous agonist
ejection as observed by an apparent desensitization of 59% in
control, and 77% under hUII perfusion. We then followed the
time-dependent recovery from desensitization in the absence or
presence of hUII. Recovering of 50% receptors from this long
exposure occurred with mean time constants of 16.2 s in control
and 82.2 s in the presence of hUII, demonstrating that the
progressive recovery is delayed in the presence of the peptide
(Figure 6). Thus, when coexpressed with UT, the pharmacological
profile of GABAAR is not altered, but UII rather affects
macroscopic a2b3c2L receptor current desensitization, and mark-
edly slows the recovering process. Since recovery from desensiti-
zation does not involved membrane voltage [60], it is suggested
that UT-mediating GABAAR desensitization is mainly due to
conformational changes of the ligand-bound receptor chloride
channel, paralleled to a mechanism known to develop from the
closed but fully bound conducting state of the receptor [61].
Mechanisms promoting fast short-term and long-term
UII-induced GABAAR current inhibition
In CHO-UT-GABAAR, the Iso-activated currents were mea-
sured during a 28-min recording period from the initial
application of the GABAAR agonist. A 1-min application of hUII
(10
28 M) provoked a fast and significant decrease of the current
(23.4462.47%, n=10) followed by a progressive run-down,
reaching 84.6165.92% (n=4) inhibition after 24-min washout
(Figure 7A). The second large intracellular loop of several
GABAAR subunits possesses numerous consensus phosphorylation
sites [62] and effective phosphorylation mechanisms have been
shown to be involved in either short- or long-term regulation of
experimental conditions (n=7–54). Data are mean 6 SEM from 3 to 54 cells. ns, non significant, *, P,0.05; ** P,0.01; *** P,0.001 compared
with the corresponding control Iso-evoked current.
doi:10.1371/journal.pone.0036319.g004
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PLoS ONE | www.plosone.org 7 May 2012 | Volume 7 | Issue 5 | e36319Figure 5. Role of specific UT ligands on cytosolic calcium in CHO-UT. (A, B) hUII (A) or URP (B) (10
28 M, each) provoked a robust increase of
[Ca
2+]c, which remained stable (A) or recovered to the basal line level (B) during washout. (C, D) Effect of the UT antagonists [Orn
5]-URP (10
26 M, C) or
palosuran (10
26 M, D), before and during hUII application. Right, bar graphs represent the percent increase of the [Ca
2+]c during drug perfusion or
during the washout period. Percent values were obtained by normalizing signals evoked during and after treatments to the value measured before
UII Receptor-Induced Down-Regulation of GABAAR
PLoS ONE | www.plosone.org 8 May 2012 | Volume 7 | Issue 5 | e36319inhibitory synaptic transmission [63,64]. To further explore the
mechanisms sustaining the hUII-induced current long-term
depression, we hypothesized that various UT-couplings to G
proteins, relay [Ca
2+]c rise resulting in kinase or phosphatase
activation, likely responsible for changes in GABAAR subunits
phosphorylation state. G-protein activation requires the exchange
of bound GDP (resting state) with GTP (activated state). This is a
common and necessary step of all G-protein mediated actions and
is independent of G-protein type or the second messenger system
involved. Therefore, blockade of this exchange will result in
inability of the ligand-bound receptor to exert its action. Thus, G
protein specific blockade with GDPbS (10
24 M) did not
significantly prevent the fast and long-term inhibition of the
current induced by hUII (Figure 7B). Intracellular dialysis with a
cocktail of kinase and phosphatase inhibitors (KIC; phosphatase
inhibitor cocktail, quercetin 10
25 M and staurosporine 10
25 M),
failed to alter the fast hUII inhibitory effect but attenuated the run-
down phenomenon (Figure 7C). It is also observed that hUII
reduced the peak current amplitude after 5-s perfusion, but evoked
a peak [Ca
2+]c increase only after a 10-s delay (Figure 7D).
Consistent with this observation, intracellular BAPTA (10
24 M)
dialysis reduced the long-term current inhibition by only
39.29610.16% (n=9) (Figure 7E). Together, these observations
tend to show that G proteins do not transduce UT-induced
current inhibition and that calcium transient and phosphorylation
mechanisms do not play a promoting role, but participate in the
run-down of the GABAAR current. To test a hypothetical role of
UII in the dynamin-dependent GABAAR endocytosis, the
dynamin inhibitory peptide DIP, which competitively blocks
binding of dynamin to amphiphysin [64], has been introduced in
the intrapipette solution. As shown in Figure 7F, when cells were
dialyzed with DIP (10
25 M), hUII retained its ability to induce a
fast and highly reversible inhibition of the Iso-evoked current, but
failed to reduce the current amplitude with time recording.
Inhibition of the GABAergic activity involves GABAAR
internalization and requires specific UT receptor domains
in CHO and human astrocytes
To assess whether the C-terminus fragment of UT, correspond-
ing to the cytoplasmic C-tail of the receptor contributes to the UII-
induced run-down of the GABAAR activity, we constructed four
truncated mutants in which the last 19 (UT
HA
370), 38 (UT
HA
351),
57 (UT
HA
332) or 70 (UT
HA
319) residues were removed (Figure 8A).
They are all present at the plasma membrane (Figure S2) and
functionally expressed except the UT
HA
319 truncated form of UT
(Figure S3). When UT
HA
370 is coexpressed with GABAAR, the
hUII-induced fast short-term inhibition was totally abolished,
whereas the long-term inhibition was delayed, and significantly
altered (Figure 8B). In the presence of shorter truncated forms,
hUII totally failed to alter the GABAAR activity, suggesting that
the most distal C-terminus part of UT is involved in the functional
cross-talk with GABAAR (Figure 8B). Moreover, the peptidomi-
ligand application. Data are mean 6 SEM from 9 to 25 cells. ns, non significant; ** P,0.01; *** P,0.001 compared with the corresponding control Iso-
evoked current. In each type of experiment, three different cells have been selected as representative exemples.
doi:10.1371/journal.pone.0036319.g005
Figure 6. UII-induced fast current inhibition and GABAAR desensitization. (A, B) Examples of currents recorded from CHO-UT-GABAAR
during a long desensitizing pulse (25 s) of Iso (10
24 M), in the absence (black line) or presence (green line) of hUII (10
28 M, 1 min). (A) Exponential fit
to the desensitizing current phases were shown overlaid on the currents. Bar graphs corresponding to the average desensitization constant
parameter t in the absence (tCtrl) or presence (thUII) of hUII (n=5). (B) Prolonged Iso (30 s) application eliciting current desenzitization followed by a
time course of the recovery from desensitization, in the absence (control) or presence of hUII. Graph represents the Iso-evoked current expressed as a
fraction of the peak control current induced by the long Iso application to the current amplitude elicited by each short pulse, and plotted against
interpulse intervals. Data are mean 6 SEM from 3 to 8 cells. *, P,0.05; ** P,0.01; *** P,0.001 compared with the corresponding control Iso-evoked
current.
doi:10.1371/journal.pone.0036319.g006
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PLoS ONE | www.plosone.org 9 May 2012 | Volume 7 | Issue 5 | e36319Figure 7. Intracellular mechanisms of UT-triggering GABAAR inhibition. (A) Traces of Iso (10
24 M, 2 s)-evoked current amplitude time-
course on CHO-UT-GABAAR, in control (above row) or during a 1-min application of hUII (10
28 M, bottom row). Corresponding average time course of
the Iso-evoked current, in control or during and after hUII application. (B, C) Current traces before (1), during (2) a 1-min hUII application and after 20-
min washout (3), in the absence or presence of GDPbS (B, 10
24 M, 15 min of dialysis) or the cocktail of kinase and phosphatase inhibitors (C, KIC,
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c-myc
319–389 (Figure 8A) completely inhibited the fast and
long-term effects of hUII on the GABA-evoked current (Figure 8C).
Collectively, these results indicate that the C-terminus of UT
relays the inhibition of the GABAAR function, and may counteract
a potential hUII-induced internalization process.
Our data thus suggest that UT activation likely regulates
GABAAR endocytosis. We first established the subcellular
localization of both UT and GABAAR in cultured CHO
transiently transfected with cDNAs encoding recombinant human
UT and the a2b3
HA-c2-tagged (a2b3
HAc2) GABAAR subunits and
then, internalization of GABAAR was followed by labeling the
surface receptors with antibodies directed against the b3
HA co-
expressed with a2c2 GABAAR subunits and/or UT. In the
absence of ligand, the immunoreactivity for b3 exhibited
membrane localization (green) as enlighted by the intensity profiles
(Figure 9Aa). In contrast, treatment with hUII (10
28 M), Iso
(10
24 M) or the two agonists, drastically promoted GABAAR
endocytosis by 40.2964.14%, 39.3162.84% and 34.7163.19%,
respectively (Figure 9B), as seen by the increase of red punctuates
in the cell soma (Figure 9Ab-8Ad). When GABAAR was expressed
alone, hUII failed to induce GABAAR internalization whereas Iso
or Iso combined with hUII remained able to provoke GABAAR
removal from the plasma membrane (Figure 9B).
In order to confirm the involvement of UII/UT in the
internalization process of GABAAR in CHO, we investigated the
plasma membrane expression of the c2
HA GABAAR subunit, as
well as UT
c-myc after exposure to hUII by measuring the amount of
surface immunolabelled receptors by ELISA. Typical biolumines-
cence and fluorescence values obtained from CHO expressing
either UT
c-myc-a2b3 or UT
c-myc-a2b3c2
HA, and UT
c-myc or UT
c-myc
-a2b3c2
HA-UT319–389YFP, respectively, were shown in Figure 10A.
In CHO-UT
c-myc-a2b3c2
HA, a 30 min treatment with hUII
(10
28 M) led to approximately 40% loss of c2
HA subunit from the
cell surface, without modifying cell membrane amounts of UT
c-myc
(Figure 10B). In CHO-UT
c-myc-a2b3c2
HA cotransfected with the
cDNA encoding the UT319–389YFP peptidomimetic fragment, hUII
incubation failed to remove the c2
HA subunit from the plasma
membrane (Figure 10B), establishing that the C-terminus part of
UT played a major role in the UII-induced GABAAR internaliza-
tion in a recombinant system. The physiological relevance of such
mechanism was thus assessed in native human astrocytes and in the
human glioma U87 cell line. Flow cytometry analysis showed that
normal and tumoral glial cells in culture expressed b3 subunit
(Figure 11A) and UT (Figure 11B), and that one population (around
8%) of astrocytes and U87 exhibited both receptors at the plasma
membrane (Figure 11). hUII (10
28 M, 30 min) provoked more than
65% GABAAR disappearance from the surface, whereas UT
internalized in native astrocytes (Figure 11A) but was still present at
the cell surface in U87 (Figure 11B). We then examined the cell
surface stability of GABAAR following UT activation in the absence
or presence of the coexpressed UT319–389YFP on U87 glioma cell
line. ELISA-based assay revealed that the UT319–389 fragment
reduced the b3-associated GABAAR subunit internalization from
20% to approximately 10% (Figure 11C), with an efficacy of
transfection of around 32%, as controlled by flow cytometry (data not
shown). As already shown in CHO, UT levels at the cell surface
remained unchanged after exposition to hUII, in the absence or
presence of the UT C-terminus (Figure 11C).
Discussion
The question of the regulation of the GABAAR plasticity and
cross-modulation in extrasynaptic glial cells by neurovascular
factors, and its functional consequence were not explored. In
rodent brain, mRNA encoding the vasoactive receptor UT are
detected in the olfactory system, hippocampus, amygdala,
tegmental nuclei, or cerebellum [27,65,66] and UII binding sites
are restricted to few areas including the cerebellar cortex [39,67].
We and others have also shown that UT receptor expression may
be specific to glial cells in vivo [40], and to astrocytes in culture
[41], as well as to brain microvascular entities (unpublished data).
In the present study, to gain insight into the regulation of the
GABAergic activity by the vasoactive peptide UII in astrocyte, the
cellular and subcellular distribution and feature of the UT
receptor, have been investigated in the cerebellum in situ, and
in astrocyte-neuron co-cultures. We showed intense UT labeling in
Purkinje cell bodies and ramifications as well as in glial Bergmann-
GFAP positive long processes where it co-localizes with c1 and, to
a lesser extent, with c2 subunits of the GABAAR, and in astrocytes
co-cultured with granule neurons. Together, this corroborates
previous studies establishing expression of a5, c1 and c3 subunits in
the PCL [68,69], and of c1 mRNA in Bergmann glia [70,71]. We
confirmed the coexpression of GABAAR subunits with UT in
native human astrocytes and in the U87 glioma cell line. It is
interesting to note that a majority of glial cells expresses at least the
b3 GABAAR subunit and also UT in the cytosolic compartments,
but that only around 10% of cells corresponding to a common
subpopulation, show these receptors at the plasma membrane.
This is in a good agreement with the 12% responding rat cultured
astrocytes to isoguvacine in mono-culture. In fact, the existence of
two populations of astrocytes, exhibiting depolarized membrane
potentials (around 230 mV) in a majority of cells and hyperpo-
larized membrane potentials (around 280 mV) in a minority (data
not shown) was observed in our study, as already shown in cultured
astrocytes [72], independent on patch-clamp recording conditions.
Here, we determined that this hyperpolarized subpopulation
represents astrocytes specifically responding to the GABAAR
activation. Since it was suggested that GABA acts as an anti-
proliferating neurotransmitter in ventricular and subventricular
zones [73] and in cortical progenitor cells [74] and that down
regulation of functional GABAAR is correlated with the prolifer-
zation rate of reactive or malignant astrocytes [15,25], we propose
that rat and human cell subpopulation expressing GABAAR likely
correspond to quiescent astrocytes in culture.
These colocalized features of UT and GABAAR in astrocytes
prompted us to investigate a potential functional cross regulation
between the two receptors, likely involved in astrocyte plasticity. It
has been shown that astrocytic GABA response is specific of early
15 min of dialysis). Note that the KIC composition consists in phosphatase inhibitor cocktail at 5 mg/ml (sodium vanadate, sodium molibdate, sodium
tartrate and imidazole), Quercetin (10 mM) and staurosporine (10 mM). In the bottom rows are represented the corresponding average time course of
the Iso-evoked current, in the absence or presence of GDPbS (B) or KIC (C). (D) Representative [Ca
2+]c (Fura-2 AM) imaging field before, during hUII
application and during washout, and time-course of the fluorescence ratio 340/380. Numbers above each curve indicate the corresponding
fluorescent image. The bottom row shows simultaneous currents evoked by repetitive Iso ejections, the time scale has been enlarged to show that
the current inhibition occurs before hUII-induced [Ca
2+]c rise. (E, F) Current traces before (1), during (2) a 1-min hUII application and after 20 min
washout (3), in the absence or presence of the rapid Ca
2+ chelator BAPTA (10
23 M, E) or the dynamin inhibitory peptide DIP (10
25 M, F). In the
bottom rows are represented the corresponding average time course of the Iso-evoked current, in the absence or presence of BAPTA (E) or DIP (F).
Data are mean 6 SEM from 3 to 21 cells. *, P,0.05; ** P,0.01; *** P,0.001 compared with the corresponding control Iso-evoked current.
doi:10.1371/journal.pone.0036319.g007
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[75]. We demonstrate that UII down regulates the Iso-evoked
depolarization and chloride current amplitudes recorded from
astrocytes co-cultured with granule neurons. This UII-induced
GABAAR current inhibition is shown to be a very high affinity
process, specific of astrocytes, which hardly recovered during
washout. In CHO co-expressing human UT and ab and/or c
GABAAR subunits, we found that UII was i) very potent on
b1/3c1/2LGABAARsubunitcomplexes,ii)lesspotentona2b1/3c1/2L
complexes and iii) inactive on ab binary complexes. These results
Figure 8. Receptor sequences involved in UT regulation of the GABAAR activity. (A) Schematic diagrams mixed with sequence alignments
of the HA epitope-tagged human UT, C-terminus truncated UT
HA
370,U T
HA
351,U T
HA
332,U T
HA
319 mutants, and peptidomimetics corresponding to the
entire C-terminus cytosolic fragment of UT (UT
c-myc
319–389). (B and C) Traces of Iso (10
–4 M, 2 s)-evoked current before (1), during (2) a 1-min hUII
(10
28 M) application and after 22-min washout (3). (B) Currents recorded from CHO coexpressing GABAAR and UT
HA (Control), UT
HA
370,U T
HA
351,
UT
HA
332 or UT
HA
319. Corresponding average time course of the current, in the absence or presence of UT truncated mutants. (C) Current traces
recorded from CHO-UT-GABAAR, in the absence or presence of UT
c-myc
319–389. Corresponding average time course of the Iso-evoked current, in the
absence or presence of UT
c-myc
319–389. In B, significance was only annotated above the time course graph during hUII perfusion and after 18-min
washout, for clarity. Data are mean 6 SEM from 3 to 13 cells. ns, non significant; *, P,0.05; ** P,0.01 compared with the corresponding control Iso-
evoked current.
doi:10.1371/journal.pone.0036319.g008
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PLoS ONE | www.plosone.org 12 May 2012 | Volume 7 | Issue 5 | e36319Figure 9. UT activation mediating GABAAR internalization. (Aa–Ad) CHO-UT transiently transfected with cDNA encoding a2b3
HAc2 GABAAR
subunits. Internalization was controlled through translocation of b3
HA subunit (red) in control (Aa) or after 60 min of hUII (10
28 M, Ab), Iso (10
24 M,
Ac) or hUII+Iso (Ad) incubation. Fluorescence intensity plots of green and red fluorescences corresponding to the localization of GABAAR( b3
HA) at the
plasma membrane and in the cytosol, respectively, across the regions delimited by the white line scans. A.u., arbitrary unit; scale bars, 25 mm. (B) Bar
graphs of the fraction of fluorescence at the plasma membrane on CHOT-UT-GABAAR or CHO-GABAAR in the different conditions. Each bar
corresponds to mean 6 SEM percent obtained from 3 to 18 cells. ns, non significant; ***, P,0.001 versus control in CHO-UT-GABAAR; ###, P,0.001
versus control in CHO-GABAAR.
doi:10.1371/journal.pone.0036319.g009
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inhibition toward the GABAAR specifically composed of the c
subunit. This observation can be paralleled to the high affinity
binding sites for UII determined on recombinant UT-expressing
cells [76,77,78,79], and also on astrocytes [41]. The time course
of the UT-evoked current inhibition can be distinguished by two
phases, i.e. a short-term decrease detected immediately after and
during UII administration, followed by a progressive run-down of
Figure 10. UII-induced GABAAR loss from the plasma membrane through the C-terminus fragment of UT in CHO. The effect of hUII on
the proportion of GABAAR and UT at the cell surface of CHO was assessed by ELISA. (A) CHO transiently transfected with cDNA encoding UT
c-myc and
a2b3,o ra2b3c2
HA GABAAR subunits (left), or UT
c-myc, and a2b3c2
HA GABAAR subunits cotransfected with the cDNA encoding UT319–389YFP (right).
Background bioluminescence (left) and fluorescence (right) were measured after anti-HA antibody and colorimetric alkaline phophatase substrate
incubation, in the absence or presence of 30 min of hUII (10
28 M, left), or directly on a fluorescent plate reader (right). (B) CHO transiently transfected
with cDNA encoding UT
c-myc and a2b3c2
HA GABAAR subunits (left), or cotransfected with the cDNA encoding UT319–389YFP, and immunodetected with
anti-HA (left) or anti-c-myc (right) antibodies. Percentage of cell surface c2
HA GABAAR subunit (left) or UT
c-myc (right) are represented as the proportion
of receptor at the plasma membrane (non permeabilized cells) to the total expressed receptor (permeabilized cells). One hundred percent
correspond to values in the absence of 30 min treatment with hUII (10
28 M, 37uC). Each bar corresponds to mean 6 SEM percent obtained from 5 to
7 independent experiments, in triplicates. ns, non significant; *, P,0.05; ***, P,0.001.
doi:10.1371/journal.pone.0036319.g010
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PLoS ONE | www.plosone.org 14 May 2012 | Volume 7 | Issue 5 | e36319Figure 11. UII-evoked GABAAR internalization in native human astrocytes and glioma. (A, B) FIow cytometric analysis of the b3 GABAAR
subunit and UT expression in native human astrocytes (A) and human U87 glioma cell line (B). Cells were stained with the anti-human b3 subunit or
anti-human UT in permeabilized or non permeabilized conditions (membrane receptor). The black lines depict results from control staining with only
secondary antibodies. The b3 GABAAR subunit or UT cell surface expression was evaluated in the absence or presence of hUII (10
28 M, 30 min) by
flow cytometry. Data obtained in A and B illustrate two representative experiments showing b3 (magenta line) and UT (yellow line) mean
fluorescence in the cytosol and at the plasma membrane of a minority of non permeabilized human astrocytes (A) or U87 (B) in culture. The exposure
to hUII induced internalization of b3 in both cell types and of UT only in U87 glioma. (C) U87 glioma cell line expressing UT and GABAAR composed of
b3 subunit, and transfected with the cDNA encoding UT319–389YFP, and immunodetected with anti-b3 (left) or anti-UT (right) antibodies. Percentage of
UII Receptor-Induced Down-Regulation of GABAAR
PLoS ONE | www.plosone.org 15 May 2012 | Volume 7 | Issue 5 | e36319the current, leading to about 80% GABAAR current disappear-
ance. However, URP which exhibits the same conserved
biologically active cyclic sequence than UII, triggers a reversible
inhibition. This is in accordance with the UII-induced long-
lasting in the one hand, and the URP-evoked transient, on the
other hand, increase in [Ca
2+]c in CHO-UT. The specific long-
lasting phenomenon might be attributable to the slow dissociation
rate of UII, as already described for rat and human UII on UT
transfected cells, skeletal muscle myoblasts and astrocytes
[41,54,79]. This could account for the sustained and washout-
resistant contractile responses induced by UII on primate arteries,
[Ca
2+]c increase in rat cortical astrocytes [42], and GABAAR
current inhibition in our native and recombinant systems. We
propose a mechanism whereby UII interacts reversibly with the
classical binding site, but also with a secondary exosite in a wash
resistant manner, resulting in persistent activation of UT and
consequently, in a long-term inhibition of the GABAAR. Such
process has already been demonstrated in vivo and cell culture, for
exogenous agonists of M1 muscarinic and b2 adrenergic receptors
[80,81]. Together, our previous work suggesting that GABA
negatively controls UT-mediating signaling transduction in
astrocytes [43], corroborated by the effect of benzodiazepines
on UII-induced neurotransmitter release [82], supports at most
the existence of a negative cross-talk coupling between UT and
the closely associated GABAAR, leading to a high affinity
functional receptor complex in astrocytes. This functional
complex may exhibit new pharmacological profile. Accordingly,
we demonstrated that [Orn
5]-URP acts as a partial agonist and
competitive antagonist on both GABA currents and [Ca
2+]c.
Surprisingly, palosuran as a specific primate UT antagonist [55],
counteracts the UII-evoked [Ca
2+]c increase but mimics the effect
of UII by inhibiting the chloride current. Thus, palosuran
behaving as an antagonist of the UT-mediating [Ca
2+]c
transduction signaling can be considered as a partial UT
‘‘agonist’’ toward the GABAAR effector pathway, then suggesting
a different UT pharmacology when co-expressed with GABAAR.
Here we found that initiation of UT and GABAAR functional
interaction is independent on G protein, calcium and phosphor-
ylation mechanisms, but that UII-induced current run-down
partially requires calcium and kinase/phosphatase activities. In
this context, the Ca
2+/calmodulin requirement for membrane
fusion in endocytic pathways [83], as well as the clathrin-mediated
internalization depending on kinase and phosphatase activi-
ties[84,85,86], support here a possible role of UT in a delayed
calcium/kinase dependent GABAAR endocytosis. GABAAR
internalization is primarily thought to occur via a clathrin- and
dynamin-dependent mechanism [87]. Here DIP, known to block
endocytosis by disrupting the interaction between dynamin and
amphiphysin, did not interfere with the UII-induced fast short-
term but totally abolished the long-term inhibition of the current,
supporting a role of UT in the dynamin-dependent GABAAR
internalization. We then show that the GABAAR agonist triggered
removal of b3 or c2 GABAAR subunit from CHO plasma
membrane, or from native human astrocytic and glioma cell
surface. Together, the interesting point resides in the ability of the
UII/UT system in the promotion of the marked GABAAR
internalization in the absence of co-activation of GABAAR. In
addition, 30 min incubation with UII failed to internalize UT in
CHO and U87, but led to UT loss from human astrocyte surface,
a discrepancy unexplained but needing further investigations.
Thus, a constitutive tight promiscuity between UT and GABAAR
might be responsible for the high affinity effect of UII on
GABAAR disappearance from the plasma membrane.
Here we produced and expressed truncated UT receptors in
order to identify which specific receptor determinants are involved
in the GABAAR modulation. The deletion of up to 57 residues of
the UT C-terminus, did not affect the expression and ability of
truncated mutants to stimulate the [Ca
2+]c, as already observed for
rat UT truncated mutants [88]. We demonstrate that the entire
UT C-terminus totally abolished the UII-mediating current
inhibition and that the most distal part likely relays the fast and
long-term inhibitions of the GABAAR function. In rat, the last 19
residues of the C-terminus contain motifs that are not crucial for
UT internalization [88]. In fact, the serine cluster localized
upstream rather displays consensus motifs for PKC and casein
kinase I important for rat UT internalization. In humans, the
distal UT C-terminus (351–389) exhibits serine residues and a
combination of two polyproline motifs (Figure 8A), the last one
possibly interacts with SH3 domain proteins [89]. Our present
data in CHO co-expressing human UT and a2b3 and c2
GABAAR and in U87 transfected with the cDNA encoding the
UT319–389 peptidomimetic, indicate that the UII-induced inter-
nalization of GABAAR formed from c2 or b3 subunit, requires at
least in part, the C-terminus fragment of UT. Therefore, the
question of whether UT and GABAAR physically associate
directly or whether SH3 proteins relayed GABAAR down
regulation, has to be elucidated. Together, the functional cross-
modulation between UT and GABAAR is mediated through the
most distal part of the UT C-terminus, which would directly
interact with c subunits, or recruit intermediate proteins
implicated in GABAAR inhibitory transactivation.
Therefore, our observations suggest a model in which UT and
GABAAR are closely associated to depress the GABAergic activity
(Figure 12). When UT and abc GABAAR subunits are co-
expressed, as in native and tumoral glial cells, UII efficiently
activates its receptor, leading to a fast short-term decrease of the
chloride current, independently of G proteins, calcium, phosphor-
ylation and endocytosis processes, and involving the last 19 amino
acids of the UT C-terminus. During washout, a long-term
inhibition referred as run-down, develops via a dynamin-
dependent internalization requiring the 351–370 sequence of
UT, and calcium- and phosphorylation-dependent endocytic
mechanisms. This directional cross-talk between UT and the
GABAAR leads to the extinction of the GABAAR expression at the
plasma membrane that would play a key role in the induction of
cell proliferation (Figure 12).
Materials and Methods
Animals
Wistar rats (Depre ´, Saint-Doulchard, France) were kept in a
temperature-controlled room (2161uC), under an established
photoperiod (lights on 07.00–19.00 h) with free access to food and
tap water. The work described in this article was carried out in
accordance with the Directive 2010/63/EU of the european
parliament and of the council of 22
th September 2010 on the
cell surface b3 subunit (left) or UT (right) are represented as the proportion of receptor at the plasma membrane (non permeabilized cells) to the total
expressed receptor (permeabilized cells). One hundred percent correspond to values in the absence of 30 min treatment with hUII (10
28 M, 37uC).
Each bar corresponds to mean 6 SEM percent obtained from at least 3 independent experiments, in triplicates. ns, non significant; *, P,0.05;
***, P,0.001.
doi:10.1371/journal.pone.0036319.g011
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Official Journal of the European Union L276/33 (20.10.2010) and
authorized by the French Ethical Committee. These experiments
were conducted under the supervision of authorized investigators
(H. Castel; authorization no. 76.98 from the Ministe `re de
l’Alimentation, de l’Agriculture et de la Pe ˆche) and were
approuved by the local animal ethic committee of Normandy,
approuval number N/02-09-09/03/09-12.
Primary Cell Culture of astrocytes and astrocyte-neurone
co-culture
Primary cultures of astrocytes were prepared as previously
described [90]. Briefly, cerebellum from 7-day-old (P7) Wistar rats
were collected in DMEM/Ham-F12 (2:1, v/v) culture medium
supplemented with 2 mM glutamine, 1% insulin, 5 mM HEPES,
0.4% D(+)-glucose and 1% of the antibiotic-antimycotic solution.
The tissues were disaggregated mechanically with a syringue
equipped with a 1-mm gauge needle, and filtered through a 100-
mm pore size mesh filter (Falcon, Becton Dickinson, Grenoble,
France). Dissociated cells were resuspended in culture medium
supplemented with 10% heat-inactivated FBS and seeded in 150-
cm
2 culture flasks (Falcon) at a density of 20610
6 cells/flask. Cells
were incubated at 37uC in a humidified atmosphere (5% CO2) and
the medium was changed twice a week. When cultures were
confluent, the flasks were gently shaken on an orbital shaker at
250 g for 2 h. Dislodged cells were discarded and a second step of
purification was performed at 250 g for 14–16 h. Remaining
adhesive cells were collected by trypsination, centrifuged (800 g,
10 min) and plated in 150-cm
2 flasks. Suspended astrocytes were
harvested and seeded in 24-well poly-L-lysine-coated plates. The
purity of the cultures was previously assessed by counting the
percentage of astrocytes immunostained with GFAP antibodies.
The enriched cultures contained .99% astrocytes [41].
For astrocyte-neuron co-culture, granule cell cultures were
prepared from cerebella of P7 Wistar rats as described previously
[91]. Isolated cells were plated on 14-mm culture dishes coated
with poly-L-lysine (5 mM) at a density of 1.5610
6 cells/dish and
incubated at 37uC in a humidified atmosphere (5% CO2) for 1 to
10 days before use. Culture medium consisted of DMEM/Ham’s
F12 (75%/25%) supplemented with 10% FBS, 2 mM glutamine,
5 mg/ml insulin, 25 mM KCl and 1% of antibiotic-antimycotic
solution. Co-cultures are obtained by seeding granule cells
(1.5610
6 cells/ml) on cerebellar astrocytes plated in 24-well plates
after 12 hours. Co-cultures are maintained in the specific medium
for neuron and incubated at 37uC in an humidified atmosphere
(5% CO2) for several days.
Human native astrocytes and glioma cell line
The human cell line from glioblastoma U87 was obtained from
the American Type Culture Collection (LGC Standards, Mol-
sheim, France). U87 cells were maintained in DMEM containing
10% FBS and 1% sodium pyruvate. NHA-Astrocytes (Lonza,
Walkersville, MD, USA) were cultivated in DMEM culture
medium supplemented with 2 mM glutamine, 5 mM HEPES,
1% non essential amino acids, 1% sodium pyruvate, B27, 25 ng/
ml EGF, 1% of the antibiotic-antimycotic solution and 10% FBS.
All cells were incubated at 37uC in a humidified atmosphere
containing 5% CO2. Culture media were replaced every three
days.
CHO recombinant cell line and plasmid transfection
CHO-K1 cell lines were obtained from American Type Culture
Collection (Manassas, VA, USA). The human UT stable CHO
(CHO-UT) was generously provided by Dr Christophe Dubessy
(Inserm, Rouen University, France) et generated by CHO
electroporation with 20 mg pIRES-neo2-UT DNA and 500 mg
Figure 12. Schematic model depicting the mechanism of UT-mediated GABAAR down-regulation. UII efficiently activates the G protein-
coupled receptor UT, leading to a fast short-term decrease of the chloride current not sustained by G proteins, calcium, phosphorylation and
endocytosis processes. This rapid effect involves the distal 19 C-terminal amino acids of UT and the presence of c subunits within of the GABAAR
complex (1). During the washout period, a long-term inhibition develops via a dynamin-, calcium- and phosphorylation-dependent endocytic
mechanisms, requiring at least in part the 351–370 sequence of UT and GABAAR c subunits (2). It is hypothesized that the directional cross-talk
between UT and GABAAR, and the extinction of the latter at the plasma membrane, may relay transition from quiescent to proliferant astrocytes.
doi:10.1371/journal.pone.0036319.g012
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electroporation system (Equibio, Angleur, Belgium), followed by
repetitive rounds of limiting dilution of cells in G-418 (400 mg/ml)
for selection. Normal or stable CHO was grown in Ham-F12
medium supplemented with 10% FBS, 1% antibiotic-antimicotic
solution and 2 mM glutamine, at 37uC in a humidified incubator
with an atmosphere of 5% CO2. The stable CHO-UT medium
was supplemented with the antibiotic G-418 (40 mg/ml).
For transfection, cells were trypsinized (0.05%), triturated in
HamF-12 containing 10% FBS media, pelleted by centrifugation,
resuspended in 100 ml solution V for nucleofection by an Amaxa
Nucleofector Device (Ko ¨ln, Germany; set to program U-016).
Experiments were performed on normal CHO or on the stable
CHO-UT cells and transiently transfected with combinations of
cDNA encoding a2b3c2, a2b3c1, a2b1c2, a2b3c1, a2b3, b3c2 (4 mg
of cDNA total/transfection) GABAAR subunits. Cells were seeded
on 14-mm poly-L-lysine-coated glass bottom insert dishes at
5610
5 cells in a volume of 0.5 ml/dish. Cells were incubated
overnight at 37uC in a humidified incubator (5% CO2) during
16 h before electrophysiological or immunocytochemical experi-
ments.
Recombinant receptors
For UT epitope-tagged with HA (UT
HA), or c-myc (UT
c-myc),
human UT receptor cDNA inserted into pcDNA3.1 (Ressource
Center, MI, USA) was amplified and PCR products were
subcloned using the EcoRI and XhoI sites of pCMV-HA or
pCMV-c-myc. Mutant UT receptor cDNAs were constructed by
oligonucleotide-directed mutagenesis (Expand High Fidelity PCR
System; Roche) using the human UT receptor cDNA inserted into
pcDNA3.1 as a template. Two sets of forward and reverse
oligonucleotides were used (Table S2) to introduce stop codons in
frame of Leu370, Phe351, Gly332 and Thr319 (to generate
UT371,U T 351,U T 332 and UT319, respectively). PCR products
were subcloned using the EcoRI and XhoI sites of pCMV-HA
after digestion by the same restriction enzymes. Mutagenesis was
confirmed by automated nucleotide sequencing.
GABAA receptor cDNA clones; a2, b1, b3, c1 and c2L
engineered into the expression vector pCDM8 (a1, b1, c2)o r
pcDNA/Amp (b3, c1), were generously provided by Dr Wingrove
(Merk Sharp and Dohme, Harlow, UK). To obtain b3
HA or c2
HA
epitope-tagged subunits, b3 or c2 cDNA was amplified and the
PCR product was subcloned using the SalI and NotI sites of
pCMV-HA (Table S2) after digestion by the same restriction
enzymes.
In order to generate mini-peptides corresponding to the
C-terminus of UT, cDNA encoding the UT
c-myc
319–389 or
UT319–389YFP fragment was amplified by PCR. The 59 and 39
oligonucleotides incorporated SalI and NotI or EcoRI and BamHI
sites, respectively, to facilitate subcloning into pCMV-c-myc or
pEYFP-N1 (BD Biosciences Clontech, Mississauga, ON, Canada),
and incorporated initiation and stop codons where appropriate
(Table S2).
Immunocytochemistry on co-culture
Astrocyte-neuron co-cultured on glass coverslips were washed
three times in PBS, fixed in 4% paraformaldehyde at 4uC for
20 min, and washed three times in PBS. Cells were permeabilized
in PBS containing 0.1% Triton X-100 (10 min) and pre-incubated
with normal goat and/or normal donkey antiserum (1:50, Santa-
Cruz, Tebu bio, Le Perray en Yvelines, France) for 1 h. Then,
cells were incubated at 20uC for 1 h with a goat anti-UT (1:200), a
mouse anti-NeuN (1:200, Santa-Cruz) or a rabbit anti-GFAP
(1:1000, Dako, Trappes, France). Specificity of the UT immuno-
labelling on astrocytes has already been demonstrated [40]. After
several rinses in PBS, cells were incubated at 20uC for 2 h with
Alexa 488-conjugated donkey anti-goat and anti-Alexa 594-
conjugated donkey anti-rabbit IgGs diluted 1:300 (Invitrogen,
Boulogne Billancourt, France).
Receptor cell surface internalization
For double-immunofluorescence, non-permeabilized living
CHO cells expressing UT and/or a2b3
HAc2 GABAA receptors
were washed two times in PBS, and incubated with monoclonal
mouse anti-c-myc and rabbit polyclonal anti-HA (1:200, Santa-
cruz) for 1 h on ice in DMEM. Excess antibody was removed and
cells were incubated with the different receptor agonists for 30 min
at RT. After several rinses in PBS, cells were fixed in 4%
paraformaldehyde at 4uC for 20 min, washed three times in PBS
and then incubated at RT for 2 h with appropriate secondary
antibodies, i.e. Alexa-488- and 594-conjugated donkey anti-mouse
IgGs diluted 1:300 (Invitrogen). After washing, coverslips were
mounted in Eukitt (VWR International, Strasbourg, France).
All preparations were examined using a confocal laser-scanning
microscope (Leica, Heidelberg, Germany) equipped with a Diaplan
optical system, a UV laser (excitation wavelength 405 nm) and
argon/krypton ion (excitation wavelengths 488/594 nm) laser.
Immunohistochemistry on cerebellar sections
Following decapitation, the cerebellum of 7-day-old (P7) Wistar
rats was extracted and immersed in iced PBS. Cerebella of P7 rats
were sectioned transversely into 180 mm-thick slices on a vibrating
blade microtome (VT1000S, Leica Instruments). The slices were
subsequently washed in PBS (pH 7.4) and postfixed in a 4% PFA
solution for 20 min. Thereafter, free-floating sections were rinsed
and non-specific binding was blocked by 10% normal donkey
serum, 0.1% BSA and 0.3% Triton X-100 in PBS for 1 h. The
tissue sections were incubated overnight at 4uC with a goat
antiserum directed against rat UT (1:200, Santa Cruz), a mouse
anti-calbindin (1:400, Sigma-Aldrich, Saint-Quentin Fallavier,
France), a mouse anti-GFAP (1:1000, Dako), a mouse anti-NeuN
raised in mouse (1:200, Santa-Cruz), an anti-doublecortin (DCX)
raised in goat (1:400, Santa-Cruz), or anti-c1 and anti-c2
GABAAR subunits (1:200, generous gift from Dr Sieghart, Brain
Research Institute, Vienna, Austria). The sections were rinsed
three times with PBS and incubated for 2 h at RT with Alexa 488-
or 594-conjugated donkey anti-rabbit, donkey anti-goat or donkey
anti-mouse (1:200, Invitrogen). After washing, slices were
incubated with 4,6-diamidino-2-phenylindole (DAPI, 1:10000,
Sigma-Aldrich) for 5 min to label nuclei. Finally, the sections were
rinsed in PBS, and mounted with mowiol. To study the specificity
of UT and other marker inmmunoreactivities, the following
controls were performed (1) substitution of each antiserum by PBS,
and evaluation of the level of fluorescence given by each type of
secondary antibody, (2) systematic mono-immunolabeling of each
protein marker. The preparations were examined on a Leica SP2
upright confocal laser scanning microscope (DM RXA-UV)
equipped with Acousto-Optical Beam Splitter (AOBS) system.
For confocal images, Alexa-488 and Alexa-594 were excited
respectively at 488 and 594 nm.
Electrophysiology
The conventional whole-cell configuration of the patch-clamp
technique was used to study the GABA-gated currents in
astrocytes and granule neurons, UT stably transfected CHO,
CHO-UT, and CHO transiently transfected with diverse variants
of UT and GABAAR subunits. After 24-h transfection, cell culture
coverslips were placed in a small chamber (1.5 ml) on a stage of a
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superfused continuously with the following bath solution contain-
ing (in mM): NaCl, 150; KCl, 2.5; HEPES, 5; CaCl2, 2; MgCl2, 1;
glucose, 10 (pH 7.4 adjusted with NaOH). The patch pipettes
were fabricated from 1.5 mm (outer diameter) soft glass tubes on a
two-step vertical pipette puller (List-Medical, L/M-3P-A, Darm-
stadt, Germany). Patch electrodes had a final resistance of 4–
6M V when filled with an internal pipette solution containing (in
mM): KCl, 130; MgCl2, 2; CaCl2, 0.5; EGTA, 5; HEPES, 10;
ATP, 1; GTP, 0.1 (pH 7.4 adjusted with KOH). ATP and GTP
were added to the internal solution used to fill electrode just before
recording. All recordings were obtained at RT with cells voltage-
clamped at 270 mV. The GABAA receptor agonist isoguvacine
was prepared in the extracellular solution and was applied to cells
by pneumatic pressure ejection. To prevent desenzitization,
isoguvacine was more often ejected during 5 s at 2-min intervals.
ATP, GTP, or guanosine 59-O-(2-thiodiphosphate) (GDPbS) were
administered through the patch pipette solution. We investigated
the effect of competitive inhibition of GDP-GTP exchange by
including GDPbS in the pipette solution (in addition to the normal
amount of GTP). For GDPbS and the KIC, immediately following
patch rupture, GABA current recordings were performed and the
experiment was commenced after an equilibration period of 15 min.
All peptide ligands, inhibitors or allosteric modulators of the
GABAA receptor function were applied via gravity through a plastic
tubing positioned in the vicinityof the cell body inorder to maintain
a sustained perfusion. In these conditions, drugs could reach the cell
of interest after 30 s of perfusion. Isoguvacine was applied focally by
pneumatic pressure ejection from a micropipette.
All current signals were amplified from an Axopatch 200A
Amplifier (Axon Instruments, Union City, CA, USA) and filtered
at 2 kHz (3 dB, four-pole, low-pass Bessel filter). Data acquisition
and analysis were performed through a digidata 1200 interface
using the pClamp 8 suite programs (Axon Instruments, Union
City, CA, USA) and/or the Origin 4.1 analysis software (Microcal
Software, Northampton, MA, USA).
The decrease of the chloride current (normalized current, I) was
defined as (I-Iso+I-UII/Iso)-1 where I-Iso+I-UII is the current
response in the presence of various concentrations of UII and I-Iso
is the control GABAAR current. Concentration response curves
were generated and the data were fitted by a non-linear regression
analysis using Microcal Origin Software. Dose-response curves
were fitted using a nonlinear square-fitting program to the
equation: F(x)=Bmax/[1+(EC50/x)
n], where x is the drug
concentration, EC50 is the concentration of drug eliciting a half-
maximal response and n is the Hill coefficient.
Cell calcium imaging
For cell calcium imaging, Fura-2 AM (5 mM, Molecular Probe;
Fisher, Cergy-Pontoise, France) was dissolved in 20% pluronic F-
127 (w/v, DMSO) and then added to culture medium at final
concentrations of 5 mM and 0.02%, with 2.5 mM probenecid
(Sigma-Aldrich) respectively. Cells were incubated in the dye
solution for 1 h in an humidified atmosphere (37uC, 5% CO2) and
then rinsed in the standard extracellular solution used for patch-
clamp experiments. For simultaneous measurements of intracel-
lular calcium and chloride-evoked currents in CHO, patch-clamp
electrodes were filled with an internal solution containing : KCl,
140; MgCl2, 4; Fura-2-pentoK, 0.25; HEPES, 10; ATP, 1; GTP,
0.1 (pH 7.4 adjusted with KOH). Fluorescence images were
acquired with the right microscope DMLFSA (Leica) equipped
with a digital CCD camera Coolsnap HQ (Photometrics, Roper
scientific, Evry, France). A high-speed scanning polychromatic
light source was used for alternate excitations at wavelenghts of
340 and 380 nm. The fluorescence intensities at both wavelenghts
(F340 and F380) were mesured every 500 ms. Image acquisition
and analysis were obtained with a MetaFluor/Metamorph
Imaging System (Roper scientific). The ratio between the two
images was proportional to the [Ca
2+]c in the cell under study.
Before an experiment, the bath ground level of fluorescence
(attributable to autofluorescence and camera noise) was deter-
mined and systematically substracted.
Cell surface expression of receptors by ELISA
Receptor surface expression was assessed by ELISA 24 h post-
transfection of CHO with cDNA encoding UT
HA or UT
HA-
truncated mutants (supplementary Fig. S2) or encoding UT
c-myc
and a2b3c2
HA GABAAR subunits, or U87 glioma cell line before
and after hUII treatment, after quantification of HA, c-myc, b3
subunit or UT immunoreactivity. Cells were plated at 50 000
cells/well in 96-well plates coated with 0.1 mg/ml poly-L-
ornithine (Sigma-Aldrich). After transfection of CHO cells with
human UT
c-myc and a2b3c2
HA and UT319–389YFP cDNA
(Supplementary Table S2), cells were serum starved for 2 h before
exposure to hUII 10
28 M during 30 min at 37uC. Cells were fixed
with 4% PFA in PBS for 5 min at RT, washed in PBS, and then
permeabilized in 0.05% triton X100 (only for permeabilized cells)
and non specific binding were blocked with PBS containing 1%
FBS for 30 min at RT. The first rat anti-HA monoclonal antibody
(0.5 mg/ml, 3F10 clone, Roche, Meylan, France or 1 mg/ml,
Santa-Cruz), mouse anti-c-myc monoclonal antibody (1.33 mg/ml,
9E10 clone, Roche), rabbit anti-UT antibody (1 mg/ml, Tebu,
Santa-Cruz) or rabbit anti-b3 antibody (1:200, Abcam, Paris,
France), were added for 1 h30 at RT. Incubation with goat anti-
rat (Thermo scientific, Fisher, Brebie `res, France), goat anti-mouse
(Santa Cruz) or goat anti-rabbit (Tebu, Santa Cruz) conjugated
alkaline phosphatase diluted at 1:1000 in PBS/FBS was carried
out for 30 min at RT. The cells were washed four times with PBS,
a colorimetric alkaline phosphatase substrate was added (Super-
Signal ELISA, Thermo scientific, Fisher) and the resulting color
reaction was measured using a Viktor multilabel plate reader
(PerkinElmer, Courtaboeuf, France). Background absorbance
from samples transfected with non-tagged receptors or from cells
without first antibodies were systematically measured. Results are
expressed as the percentage of membrane receptor corresponding
to the proportion of receptor at the plasma membrane (non
permeabilized cells) to the total receptor (permeabilized cells), and
normalized to the values obtained in the absence of UII. All
experiments were done at least three times in triplicates.
Receptor expression by Flow cytometry
Human astrocytes and glioma U87 grown in 75-cm2 flasks until
confluence were washed in PBS, detached and spun down at 4uC.
The cell pellet was washed, re-suspended in PBS containing 1%
BSA and incubated with 10 mg/mL non-immune rabbit IgGs for
30 min. For total receptor detection, cells were permeabilized in
PBS containing 1% BSA and 0.1% saponin for 30 min. Then,
cells were incubated with antibodies directed against rabbit anti-b3
subunit (1:100, Abcam) or anti-UT (1:100, Santa Cruz), diluted in
PBS containing 1% BSA and 0.1% saponin at RT (22uC) for
30 min. Non permeabilized cells were directly incubated with
rabbit IgGs (10 mg/ml, 30 min), and exposed to the first antibodies
for 30 min at 4uC. In negative controls, the primary antibodies
were omitted. Cells were incubated with an FITC- or PerCP-
conjugated goat anti-rabbit secondary antibody (Santa Cruz)
diluted 1:200 and measured in the FL1 (530 nm) or FL3 (670 nm)
channel. Cells were analyzed on a FACScalibur flow cytometer
(BD Biosciences) operated with the Cell QuestTM software.
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as control to normalize mean fluorescence levels. Dead cells and
debris were excluded from the analysis by gating living astrocytes
or glioma cells from size/structure density plots. Data were
displayed on a logarithmic scale in arbitrary units corresponding to
the mean fluorescence intensity. Each histogram plot was recorded
from at least 10,000 gated events.
Calcium mobilization assay
CHO cells stably transiently transfected with the human UT
HA
or their truncated forms were plated at a density of 4610
4 cells/
well in flat clear bottom black 96-well plates. After 24 h in culture,
cells were incubated at 37uC with 40 mlo f2mM Fluo-4 AM dye
containing 20% pluronic acid for 40 min in a 5% CO2
atmosphere. Cells were washed twice with modified HBSS, and
the effects of graded concentrations of UII on [Ca
2+]c were
measured with a fluorometric imaging plate reader FlexStation II
(Molecular Devices, Sunnyvale, CA) during 150 s with an
excitation wavelength of 480 nm and an emission wavelength of
525 nm. After 18 s recording in basal conditions, 50 ml of graded
concentration of UII (four-fold final concentration) was added to
the incubation medium with a built-in eight-channel pipettor to
assess activity. After subtraction of mean fluorescence background,
baseline was normalized to 100%. Fluorescence peak values were
determined for each concentration of UII, and potency (IC50) and
efficacy (Emax) were calculated with the Prism 4.0 software using a
logistic equation. Results were expressed as mean 6 SEM.
Chemicals
Rat UII (rUII, pQHGTAPECFWKYCI), human UII (hUII,
ETPDCFWKYCV), URP and [Orn
5]URP were synthesized by
the solid phase methodology on a Pioneer PerSeptive Biosystem
peptide synthesizer (Applera France, Courtabœuf, France) using
the standard manufacturer’s procedures as previously described
[32]. All peptides were purified on a 2.2625-cm Vydac C18
column (Alltech, Templemars, France) (.98% pure) and charac-
terized by MALDI-TOF MS on a Voyager DE-PRO mass
spectrometer (Applera France). B27, DMEM, glutamine, HEPES,
non essential amino acids, sodium pyruvate and the antibiotic-
antimycotic solution were purchased from Invitrogen (Fischer,
Illkirch, France). EGF was obtained from Abcys (Les Ulis, France).
ATP, GTP, guanosine 59-[bthio]triphosphate (GDPbS), the
GABAA receptor agonist isoguvacine, pentobarbital, poly-D-
ornithine, methyl 6,7-dimethoxy-4-ethyl-b-carboline-3-carboxyl-
ate (DMCM), a phosphatase inhibitor cocktail 2 (sodium vanadate,
sodium molibdate, sodium tartrate and imidazole), quercetin,
staurosporine, picrotoxin, SR95531, Ham-F12, insulin, D(+)-
glucose, Tri-reagent, probenicid, and bovine serum albumin
(BSA) were obtained from Sigma. FBS was from Eurobio or
Lonza (France). Pluronic acid and Fura-2 pentapotassium (Fura-2
AM pentoK) salt and Fura-2 acetoxymethyl ester (Fura-2 AM)
were from Molecular Probes (Leiden, Netherlands). The dynamin
inhibitory peptide (DIP) was obtained from Tocris Bioscience
(Ellisville, MI, USA).
Statistics
All data are presented as mean 6 SEM. Statistical comparisons
were assessed with One-way ANOVA followed by Mann and
Whitney, Newman-Keuls or Freidman post hoc tests, as relevant,
P,0.05 was taken as significance.
Supporting Information
Figure S1 Pharmacological and gating properties of
hUII-induced regulation of GABAAR. (A) Iso-evoked current
in the absence or presence of pentobarbital (10
25 M), SR95531
(10
25 M) and picrotoxin (10
24 M, 2 s) in CHO-GABAAR. Right,
summary of the effects of modulators on the GABAergic activity.
(B) Current-Voltage (I–V) relationship of the Iso-evoked current,
in the absence or presence of hUII (10
28 M). Data are mean 6
SEM from 5 to 9 cells. *, P,0.05; **, P,0.01; ***, P,0.001
compared with the control Iso-evoked current. Ns, non significant.
(PPT)
Figure S2 Expression of the UT C-terminus truncated
mutants. (A) Confocal microscope images of CHO expressing
UT
HA,U T 319
HA,U T 332
HA,U T 351
HA,U T 370
HA (green). (B)
Expression of the different UT
HA mutants expressed as receptors
in whole cells (permeabilized) or only at the cell plasma membrane
(non-permeabilized) using anti-HA antibody. Data are mean 6
SEM from a representative experiment in triplicate. *, P,0.05;
**, P,0.01; ***, P,0.001 compared to control. Mock, empty
pCMV-HA vector.
(PPT)
Figure S3 Functional expression of the UT C-terminus
truncated mutants. (A) Dose-response curves of the mean of
maximum amplitude of [Ca
2+]c transients induced by hUII in
CHO expressing UT
HA,U T 319
HA,U T 332
HA,U T 351
HA,U T 370
HA.
The results are expressed as percentages of the corresponding
control values in the absence of hUII. (B) Corresponding table
summarizing EC50 values and percentage of efficacy of the effect
of hUII on each UT construction. Data are mean 6 SEM from 3
independent experiments in duplicate. The Pearson coefficient r
2
close to 1 is used for significance.
(PPT)
Table S1 EC50 and maximum inhibitory effects of hUII
on different GABAAR subunit combinations. Data are
mean 6 SEM from 3 to 23 independent experiments. ND, not
determined; r
2, Pearson coefficient.
(PPT)
Table S2 Primer sequences and restriction enzymes
used for the different UT and GABAAR subunit construc-
tions.
(PPT)
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